RxDoctor Payments Data

Jared Melman, DPM

Foot & Ankle Surgery · Woodbridge, VANPI 1922627025

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Novabone Products at 36.2% of the total. 2025 is the largest year on record at $7,352, more than ten times the $64 reported in 2021.

$13,803in general payments, 2019–2025

Across 91 payments — averaging $151.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novabone Products$5K
  • Medline Industries LP$2K
  • Ossio Inc$2K
  • Exactech, Inc.$1K
  • Stryker$880
  • Linvatec Corporation$442
  • plus $3K from 28 others

What the payments were for

  • Consulting fees$6,50047%
  • Travel & lodging$1,90914%
  • Food & beverage$5,39539%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,803 in reported general payments places this provider in the 80th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$265,033
Medicare patients
459
Services billed
3,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole46$805
Ammonium Lactate48$578
Cephalexin35$193
Gabapentin11$79
Meloxicam15$33

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Woodbridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →